Trial Profile
Clinical Trials Insight: 700027544
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Aug 2010
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- 23 Aug 2010 Resuls presented at the 40th Annual Meeting of the International Continence Society and the 35th International UroGynecological Association (Joint Meeting).
- 29 Sep 2009 Results have been presented at the 39th Annual Meeting of the International Continence Society.
- 11 Oct 2007 Results reported at the ICS 2007.